Neurotrope (NTRP) EBITDA US GAAP (year values) |
|||||||||
2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
EBITDA, bln rub | ? | -11.0 | -15.1 | -5.08 | -7.28 | -8.55 | -5.76 | ||
Changes by years, y/y, % | -13% | +37% | -66% | +43% | +17% | -7.5% |
Neurotrope. EBITDA US GAAP, bln rub
Neurotrope. EBITDA US GAAP, changes, %
Neurotrope. EBITDA US GAAP, sum by quarters, bln rub
Neurotrope (NTRP) EBITDA US GAAP (quarter values) |
||||||||
2020Q3 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
EBITDA, bln rub | ? | -4.27 | -1.92 | -1.72 | -1.28 | -0.844 | -5.76 | |
Changes by years, y/y, % | +12% | |||||||
Changes by quarters, q/q, % | +46% | -55% | -10% | -25% | -34% |